FHIP1B (NM_032127) Human Untagged Clone

CAT#: SC315038

FAM160A2 (untagged)-Human family with sequence similarity 160, member A2 (FAM160A2), transcript variant 1


  "NM_032127" in other vectors (4)

Reconstitution Protocol

USD 994.00

5 Weeks*

Size
    • 10 ug

Product Images

Frequently bought together (4)
FAM160A2 Antibody - N-terminal region
    • 100 ul

USD 539.00


TurboFectin Transfection Reagent (1 mL in 1 vial)
    • 1 ml in 1 vial

USD 507.00


DH5α Chemically Competent Cells (≥10^8 cfu/μg of pUC19 DNA)
    • 5 x 200 ul

USD 160.00


Forward sequencing primer VP1.5, Reverse sequencing primer XL39, 100pmoles each
    • 100 pmol

USD 59.00

Other products for "FHIP1B"

Specifications

Product Data
Type Human Untagged Clone
Tag Tag Free
Symbol FHIP1B
Synonyms C11orf56; FAM160A2; FHIP
Vector pCMV6 series
Sequence Data
>NCBI ORF sequence for NM_032127, the custom clone sequence may differ by one or more nucleotides
ATGGAGAGGATGAATTGGCTGAGCAGACTGGCCTCCCGGGGCCCTGGGCACCGTATACCT
CAAGGGGCCAATCTCCAAACCCCAGTCATGGCTGATCCCGAGACCTGCCTCATGGTCTTC
AAGAATCACTGGTCCCAGGTGGTGCGAATCCTGGAGCGGCAAGGCCCTCGGGCAGCTCCT
GGGGGTGCAGACGATCTCAGTGCTGTGCGCAACCACACTTACCAGATGTTGACACTGCTG
GCAGAGGACCGTGCAGTTCCCTCGGCCCCCACAGGCCCTGGGTCCCTGCTGGAGTTTGCT
CTGCACGAGGATCTGCTGACCCGTGTGTTGACATGGCAGCTGCAATGGGATGAGCTTGGG
GATGGGGTCGAGGAACGGCGGGCTGAGCAACTGAAACTATTTGAAGTGCTAGTGAGCGAA
GCTCGCCAGCCACTGTTGCGGCATGGTCCAGTTCGTGAGGCTCTGCTCACCCTGCTGGAT
GCCTGTGGCCGCCCTGTGCCCAGTAGCCCAGCACTGGATGAAGGCTTGGTGCTACTTCTC
AGCCAGCTGTGTGTTTGTGTGGCCCAGGAGCCTTCATTGCTCGAGTTCTTCCTGCAGCCA
CCTCCTGAGCCTGGAGCCGCTCCCCGTCTTCTTCTCTTTTCTCGCCTTGTCCCTTTTGTG
CATCGAGAGGGCACCCTGGGCCAGCAGGCCCGTGATGCCCTACTTCTTCTCATGGCTTTG
TCAGCTGGGAGCCCCACTGTGGGCCGCTACATCGCGGATCACTCTTACTTCTGCCCGGTG
CTGGCCACAGGGCTCAGTGCCCTGTACTCATCACTGCCTCGAAAGATTGAGGTTCCAGGG
GATGATTGGCACTGTCTGCGACGGGAAGACTGGCTGGGAGTGCCAGCCCTTGCACTCTTC
ATGAGTTCCCTGGAGTTCTGCAATGCAGTAATTCAGGTGGCTCACCCCCTGGTGCAGAAG
CAGTTGGTTGATTATATCCATAATGGGTTCCTGGTGCCTGTCATGGGTCCTGCCTTGCAC
AAGACCTCTGTGGAGGAGATGATCGCCAGTACCGCCTACCTGGAACTTTTCCTACGGAGT
ATCTCAGAGCCTGCTTTGCTCCGTACCTTCCTGCGATTCCTGTTGTTGCACCGGCATGAC
ACCCACACCATCCTCGACACCCTCGTTGCTCGTATTGGCAGTAACTCCCGGCTCTGCATG
GTCTCTCTGAGTCTCTTCAGGACCCTCCTGAACCTCAGCTGTGAGGATGTCCTGCTGCAG
CTGGTTCTCAGGTATCTTGTTCCATGTAACCACGTTATGCTGAGCCAGAAGCCGGCTGTT
CGTGATGTGGACCTATATGGACGAGCAGCTGACAAGTTTCTCTCCCTAATCCCACGCTGT
TGTCGGCACCACGCCCCCAGCCCACCTCGTCCAGAGCATGCCTCATGGGCACGAGGTGGG
CCTAGCAGAGAGACAGGGAGAAGGGAGGACATCACGGGTCCTGGAAGCCCAAGTGTGGAC
TCCTCTTCTGTGACGACAGTACCCCGGCCCTCCACACCATCTCGTCTGGTTCTCTTCCTG
CGGCAGCAGAGCCTGGGTGGCTCTGAGTCTCCAGGCCCAGCCCCTTGCTCACCAGGGCTT
TCTGCATCCCCCGCCTCCAGCCCTGGCCGACGGCCTACCCCTGCAGAGGAGCCTGGAGAG
CTGGAAGACAATTACCTGGAGTATCTGCGTGAGGCACGTCGTGGTGTGGACCGCTGTGTC
CGAGCCTGCCGTACCTGGTCTGCCCCCTATGATGGCGAGCGGCCCTCTCCTGAGCCCAGT
CCTTTTGGCTCCCGGACTAAGAAACGCAGCCTACTGCCTGAGGAGGACAGGAACAACGTG
GGGGAAGGGGAGGAGGAAGAGCTGGGGAGGAGGGGGCGGGCTGGGGGTGCAGGGGAGGGC
CCTGGTCACCTGCCCCCTCCCCAGCTCAATGGAGTGCCAGGATCATGGCCTGAGGGGGCC
AAGAAGGTTCGTCTGGTGCCAAAGGAGGGAGCTGGGGAACTGCTAGAGGGCATCTCCGAG
GGCATGGCAGGACTAGAGGGCTTTGGGCAGGAGCTCCGGGAGCTAGAGGTGGCATTGAGC
AATGGGGGAACTGGCTCAGAGTCCCCCTTAGAACCTCCACTGCCCCTTGAGGAGGAGGAG
GCCTACGAGAGCTTCACCTGTCCCCCTGAGCCCCCTGGCCCCTTCCTCAGCAGCCCTTTG
CGGACTCTCAACCAGCTGCCAAGCCAGCCCTTCACTGGCCCCTTCATGGCTGTGCTCTTT
GCCAAACTCGAGAACATGCTGCAGAACTCCGTCTATGTCAACTTCCTGCTGACGGGGCTG
GTGGCCCAGCTGGCCTGTCACCCCCAGCCCCTGCTCCGCTCTTTCCTGCTCAACACCAAC
ATGGTCTTCCAGCCCAGTGTCAAGTCCCTGCTGCAGGTGCTGGGCTCTGTGAAGAATAAG
ATTGAGAACTTTGCGGCTTCCCAGGAGGACTTCCCAGCACTGCTGTCCAAAGCCAAGAAG
TACCTCATTGCCCGTGGCAAGTTGGACTGGGCTGAGGGCCCTGCAGCAGGACCTGCCCCA
CGCCGTTCTGATCCCCTAGTGAAGAGCCGGAGGCCATCCTTGGGGGAGTTACTCCTGCGG
CATGCACACAGTCCAACCAGGGCCCGGCAGGCGGCACAATTGGTCCTTCAGCCTGGGCGA
GACGGAGCAGGACTTGGCCTAAGTGGGGGCTCCCCTGGGGCTTCAACTCCAGTTCTACTC
ACCCGGGGCGGGGCCCCTGAACGCCAAGGTGAGGCTCTTCGAGTCAAGAATGCTGTCTAC
TGTGCAGTCATTTTCCCTGAATTTCTCAAGGAGTTGGCTGCCATCTCCCAGGCTCATGCC
GTCACCTCGCCTTTCTTGTTGGAGACTTCAGAGGAAGGATCTGGCCCTCTCATCTCAGGC
TGTGGGCCCCTCAATCCT
Restriction Sites Please inquire     
ACCN NM_032127
OTI Disclaimer Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP).
OTI Annotation This TrueClone is provided through our Custom Cloning Process that includes sub-cloning into OriGene's pCMV6 vector and full sequencing to provide a non-variant match to the expected reference without frameshifts, and is delivered as lyophilized plasmid DNA.
Product Components The ORF clone is ion-exchange column purified and shipped in a 2D barcoded Matrix tube containing 10ug of transfection-ready, dried plasmid DNA (reconstitute with 100 ul of water).
Reconstitution 1. Centrifuge at 5,000xg for 5min.
2. Carefully open the tube and add 100ul of sterile water to dissolve the DNA.
3. Close the tube and incubate for 10 minutes at room temperature.
4. Briefly vortex the tube and then do a quick spin (less than 5000xg) to concentrate the liquid at the bottom.
5. Store the suspended plasmid at -20°C. The DNA is stable for at least one year from date of shipping when stored at -20°C.
Reference Data
RefSeq NM_032127.1, NP_115503.1
RefSeq Size 3433 bp
RefSeq ORF 2961 bp
Locus ID 84067
UniProt ID Q8N612
Cytogenetics 11p15.4
Gene Summary The protein encoded by this gene is part of the FTS/Hook/FHIP (FHF) complex, which can interact with members of the homotypic vesicular protein sorting (HOPS) complex. This interaction suggests that the encoded protein is involved in vesicle trafficking. [provided by RefSeq, Dec 2016]
Transcript Variant: This variant (1) represents the longer transcript and encodes the longer isoform (1).

Other Versions

{0} Product Review(s)

0 Product Review(s) Submit review

Be the first one to submit a review

Product Citations

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.